Cargando…
Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
To evaluate the outcomes and feasibility of stereotactic body radiotherapy (SBRT) for cT3 and cT4N0M0 non–small cell lung cancer (NSCLC), 25 patients with localized primary NSCLC diagnosed as cT3 or cT4N0M0, given SBRT between May 2005 and July 2013, were analyzed. All patients had inoperable tumors...
Autores principales: | Eriguchi, Takahisa, Takeda, Atsuya, Sanuki, Naoko, Nishimura, Shuichi, Takagawa, Yoshiaki, Enomoto, Tatsuji, Saeki, Noriyuki, Yashiro, Kae, Mizuno, Tomikazu, Aoki, Yousuke, Oku, Yohei, Yokosuka, Tetsuya, Shigematsu, Naoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915546/ https://www.ncbi.nlm.nih.gov/pubmed/26983978 http://dx.doi.org/10.1093/jrr/rrw023 |
Ejemplares similares
-
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
por: Narita, Atsuya, et al.
Publicado: (2019) -
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014) -
Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
por: Nemoto, Takafumi, et al.
Publicado: (2022) -
Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
por: Hara, Yu, et al.
Publicado: (2016) -
Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer
por: Sanuki, Naoko, et al.
Publicado: (2022)